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Melanin provides inherent protection against skin cancer by absorbing broad-spectrum radiant energy of UV radiation. Cutaneous
malignant melanoma incidence has recently been observed to increase and the frequency is closely associated with the skin color,
highlighting the importance of skin pigmentation. Here, we showed how melanin biosynthesis is enhanced by treatment with
phenolic compounds-rich Cymbopogon schoenanthus (CYM) in B16 murine melanoma cells and human epidermal melanocytes
(HEM). CYM increased the melanin content of the cells by upregulating the expression of tyrosinase (TYR), tyrosinase-related
protein 1 (TRP1), and dopachrome tautomerase (DCT) at the protein and mRNA levels, comparable to the effect of 𝛼-melanocyte-
stimulating hormone (MSH), in both B16 cells and HEM. Moreover, global gene expression analysis showed that at least 44
pigmentation-associated genes were modulated, including the microphthalmia-associated transcription factor (Mitf) and its
transcriptional regulators (Sox10, Pax3, and Lef1). Upregulation of copper transport-associated gene Atp7b indicates that CYM also
promotes tyrosinase activity. CYM upregulatedMitf and possibly activates tyrosinase enzyme, providing evidence for its possible
use to promote melanogenesis and as a therapeutic agent against hypopigmentation disorders.
1. Introduction
Skin pigmentation is our first line of defense against the
harmful UV radiation, which is considered as one of the
major risk factors for melanoma skin cancer. Annually,
132,000 individuals are diagnosed with melanoma, and it
is believed that as the ozone layers are depleted, more UV
radiation from the sun reaches the earth and will increase
the incidence of skin cancers [1]. Moreover, the increase in
sunburn and the use of tanning beds have been reported to be
in an alarming situation now and contribute to the increase
in the risk of cutaneous melanoma, especially in young
individuals and in predominately fair-skinned populations
[2, 3]. The amount of melanin produced by melanocytes is
considered to be the most useful predictor of risk for skin
cancer so that highly pigmented skin provides protection
against skin cancer by 500–1000-fold [4, 5]. Melanocytes,
which contain specialized organelles called melanosomes,
produce the pigment melanin. Melanins are strong light
scatterers with a broad UV-visible absorption spectrum,
providing protection not just to melanocytes but also to
keratinocytes and other cells in the epidermis against UV
radiation-induced damage (photoproducts and oxidative
stress). Melanin can absorb a portion of the UV energy
and transform it into heat that is dissipated into the body
[6, 7]. Melanin biosynthesis occurs through an oxidation
process, starting with the amino acid L-tyrosine, with the
rate-limiting enzyme tyrosinase (TYR), catalyzing three dis-
tinct reactions: hydroxylation of L-tyrosine, dehydrogenation
of L-DOPA, and dehydrogenation of DHI, with L-DOPA
as the cofactor in the first and third reactions [4, 8, 9].
Other reactions are mediated by tyrosinase-related protein
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(TRP1) and dopachrome tautomerase (DCT) that catalyze the
tautomerization of indolene-2-carboxylic acid-5, 6-quinone
or dopachrome and oxidation of 5,6-dihydroxylindole-2-
carboxylic acid, respectively [10]. The expression of the
melanogenic enzymes Tyr, Trp1, and Dct is regulated by
the helix-loop-helix transcription factor microphthalmia-
associated transcription factor (Mitf).
Recent researches focus on the regulation of pigmen-
tation at the molecular level to promote melanogenesis as
a possible therapeutic strategy against UV-induced DNA
damage and skin cancer. Since individuals with lighter skin
color are more likely to develop skin cancer than those with
darker skin color [11], increasing skin pigmentation using
materials considered to be safe for use can therefore be
considered as the best strategy to provide protection against
UV or to attain darker skin color without resorting to use of
skin cancer-inducing tanning beds.
Recently, the acceptance into mainstream medicine of
mixtures of combination of plant natural products that may
affect multiple pharmacological targets beyond the reach
of single-compound-based drugs has been suggested [12].
We have previously reported that ethanol extract of Cymbo-
pogon schoenanthus (CYM) provides beneficial effect against
stress in ICR mice subjected to forced swimming and tail
suspension tests and the effect was attributed to its major
components quercetin-3-rhamnoside, trans-cinnamic acid,
resorcinol, caffeic acid, 2.5-dihydroxybenzoic acid, ferulic
acid, and gallic acid [13]. In pigment cells, oxidative stress
causes a downregulation of the melanogenic enzymes TYR,
TRP1, and DCT and their transcription factor MITF, leading
to decreased melanin biosynthesis [14, 15]. And although the
anti-stress effect of CYMhas been tested, its effect onmelano-
genesis has not yet been determined. Therefore it is of major
interest to characterize how CYM can regulate pigment cell
function and identify the molecular mechanism underlying
its effect. In this study, the effect of CYM onmelanogenesis in
B16 cells and human epidermal melanocytes was evaluated.
2. Materials and Methods
2.1. Cell Lines and Cell Culture. Murine B16F10 melanoma
cells or B16 cells (Cell No. RCB2630) used in this study
were obtained from the Riken Cell Bank (Tsukuba, Japan)
and maintained in Dulbecco’s modified Eagle’s medium
(Nissui, Tokyo, Japan) supplemented with 10% fetal bovine
serum (Sigma, St. Louis, MO, USA), 4mM L-glutamine
(Sigma), 50 units/mL penicillin, and 50 𝜇g/mL streptomycin
(Cambrex, East Rutherford, NJ, USA) and incubated at 37∘C
in a humidified atmosphere of 5% CO
2
. Human epidermal
melanocytes (HEM) were obtained from Cell Applications,
Inc. (San Diego, CA, USA) (Cat. No. 104K-05a), maintained
in melanocyte growth medium (Cell Applications, Inc.),
incubated at 37∘C in a 5% CO
2
humidified incubator, and
expanded for at least five passages.Themedium was changed
twice a week and subcultured when it was about 80%
confluent.
2.2. Plant Samples, Preparation, and Extraction. Leaves of
Cymbopogon schoenanthus sp. were collected from Tunisia
and identified at the Ecology Laboratory, Institut des Regions
Arides (IRA), Tunisia, while voucher specimens of the leaf
samples (UT-ARENA-00709) were deposited in the Alliance
for Research on North Africa, University of Tsukuba, Japan.
Extract ofC. schoenanthus (CYM)was prepared as previously
reported [13]. Briefly, 10 g of leaves of air-dried C. schoenan-
thus was macerated in 100ml 70% ethanol and kept for two
weeks at room temperature. The liquid fraction was then
collected and, prior to use, was filtered using a 0.22𝜇m filter
(Millipore, USA) and stored at −80∘C. As a reference or
positive control, 400 nm 𝛼-MSH or [Nle4, D-Phe7]-D-Phel,
melanocyte-stimulating hormone trifluoroacetate salt (≥95%
purity) purchased from Sigma was used.
2.3. Cell Proliferation Assay. The effect of CYM on B16 cells
proliferation was assessed using the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide or MTT assay
(Dojindo, Japan). B16 cells (3 × 104 cells/well) were seeded
onto 96-well plates and cultured as described above. After
24 h of incubation, the medium was replaced with a fresh
medium with or without the sample at various concentra-
tions. MTT (5mg/ml) was then added; the plates covered
with aluminum foil and were incubated further for 28 h.
Sodiumdodecyl sulphate (SDS; 10%)was then added at 100𝜇l
per well and incubated overnight at 37∘C to dissolve the
formazan completely. Absorbances were obtained at 570 nm
using a microplate reader (Powerscan HT; Dainippon Phar-
maceuticals USA Corp., NJ, USA). To correct the absorb-
ances, blanks containing only medium MTT and SDS were
used.
2.4. Melanin Assay. B16 cells were cultured at a density of 5 ×
105 cells per 100-mm Petri dish. After overnight incubation,
the culture medium was replaced with DMEM medium
containing either 400 nM 𝛼-MSH or different dilutions of
C. schoenanthus ethanol extract. Cells were treated with 𝛼-
MSH served as positive control. After incubation for 48 h,
the medium was then removed and the cells were washed
twice with phosphate-buffered saline (PBS) and harvested by
trypsinization (0.25% trypsin/0.02% EDTA in PBS; Sigma).
The harvested cells were pelleted and solubilized using 0.1%
Triton X-100 and then purified by precipitation in 10%
trichloroacetic acid. The isolated melanin was then dissolved
in 8m NaOH, followed by incubation for 2 h at 80∘C.
The amount of melanin in the solution was determined
spectrophotometrically at 410 nm. The total melanin content
was estimated using the standard curve for synthetic melanin
and expressed on a per viable cell basis and as percentage
of control. The cell viability and total number of cells were
assessed using the Guava PCA ViaCount Program (GE
Healthcare, UK, Ltd., Buckinghamshire, UK).
2.5. Western Blotting. B16 cells or HEM were treated with
or without CYM or 𝛼-MSH for 24 h and the protein
samples were extracted using radio-immunoprecipitation
assay (RIPA) buffer (Sigma, USA) following the manufac-
turer’s instructions. Protein samples (10 𝜇g) were resolved in
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10% sodium dodecyl sulphate-polyacrylamide gel by elec-
trophoresis (SDS-PAGE), transferred to PVDF membrane
(MerckMillipore, USA), and blotted with primary antibodies
for tyrosinase (TYR), tyrosinase-related protein 1 (TRP1),
dopachrome tautomerase (DCT), and GAPDH. All the anti-
bodies were obtained from Santa Cruz Biotechnology, Inc.,
USAwith catalog numbersC-19 (TYR),G-9 (TRP1), DCT (B-
7), and SC-32233 (GAPDH). The signal was visualized using
LI-COR Odyssey Infrared Imaging System after reaction
with goat anti-mouse IRDye 680LT, donkey anti-goat IRDye
800CW (LI-COR), or goat anti-rabbit IRDye 800CW (LI-
COR).The band intensities in western blots were determined
using LI-COR Odyssey System.
2.6. DNAMicroarray. To determine themechanism underly-
ing the effect ofC. schoenanthus onmelanogenesis, a genome-
wide expression analysis was performed using Affymetrix
(Santa Clara, CA, USA) GeneChip Mouse Genome 430
2.0 Array following the manufacturer’s instructions. Labeled
B16 cRNAs (1 𝜇g) from CYM-treated and control cells were
amplified, labeled, and hybridized onto the array. Analysis of
gene significance was done using Partek Express Software
(Partek, Inc., Chesterfield, MO, USA) while Mouse Genome
Informatics (MGI) was used as a database resource for the
GOannotations. Changes in gene expressionwere considered
significant when up- or downregulated by at least 1.5-fold by
CYMversus control (untreated). Pathway Studio analysis was
done using Elsevier Pathway Studio 11.2.5.6.
2.7. Quantitative Real-Time PCR. Total RNA was extracted
using Isogen reagent (Nippon Gene, Tokyo, Japan) following
the manufacturer’s instructions. RNA (1 𝜇g) was reverse-
transcribed using the SuperScript III reverse transcriptase kit
(Invitrogen, Carlsbad, CA, USA). Primers specific to tyrosi-
nase (Tyr), tyrosinase-related protein 1 (Trp1), dopachrome
tautomerase (Dct), and microphthalmia-associated tran-
scription factor (Mitf) were used for quantitative real-time
PCR performedwith a 7500 Fast Real-time PCR system using
TaqMan Universal PCR mix and TaqMan probes (Applied
Biosystems, Foster City, CA, USA). All reactions were run
in triplicate, and data were analyzed using the 2−ΔΔCT values
method.
2.8. Statistical Evaluation. Mean values ± SEM were calcu-
lated from three samples of at least three trials. The statistical
analyses of the results were performed using Student’s 𝑡-test
to determine the significance of results of the treated cells
versus that of the control (untreated). A value of 𝑃 ≤ 0.05
was considered significant.
3. Results
3.1. CYM Stimulates Melanin Biosynthesis in B16 Cells. The
melanin assay results showed an increase in the melanin
content of B16 cells treated with CYM. CYM at 1/10,000 v/v
had higher melanin content compared to the control (by 6%)
while 1/1000 v/v CYM increased the melanin content by 30%,
48 h after treatment (Figure 1(a)). CYM at 1/100 v/v appeared
to have lower melanin content but this was due to the slight
cytotoxicity of the extract at this concentration. The viability
of the cells used in the quantification of intracellular melanin
was not affected by 1/10,000 v/v and 1/1,000 v/v CYM. For the
succeeding experiments, CYM at 1/1,000 v/v was used.
3.2. CYM Increases the Expression of Melanogenic Enzymes
in B16 Cells. To determine if the increase in melanogenesis
was caused by an increase in the melanogenic enzymes
tyrosinase (TYR), tyrosinase-related protein 1 (TRP1), or
dopachrome tautomerase (DCT) expression, total protein
of B16 cells treated with or without 1/1,000 v/v CYM or
𝛼-MSH was extracted and western blotting was carried
out. Results showed that, compared with the control, CYM
promoted the expression of TYR, TRP1, and DCT, although
the increase ismore pronounced in TYR andTRP1 thanDCT.
The expression levels of all the melanogenic enzymes were
increased by 𝛼-MSH (Figures 1(b) and 1(c)).
3.3. CYM Promoted Melanin Biosynthesis in Human Epi-
dermal Melanocytes. To determine if the observed effect of
CYM on melanin biosynthesis on murine B16 cells is the
same on human pigment cell, the melanin content of human
epidermal melanocytes (HEM) treated without or with CYM
was determined. Results of MTT assay, used to determine
noncytotoxic concentrations of HEM, showed that CYM has
no cytotoxic effect on HEM at 1/10,000 and 1/1,000 v/v while
1/100 v/v has slight cytotoxicity and decreased melanocyte
proliferation by about 10% (Figure 2(a)). CYM at 1/1000 v/v
was then used in the succeeding experiments. Melanin
assay results showed that CYM treatment induced a twofold
increase in the melanin content of HEM (bar graph) without
affecting the cell viability (line graph) (Figure 2(b)). However,
unlike in the B16 cells, the growth medium color of CYM-
treated cells was observed to be darker in color compared to
the untreated cells’ growthmedium prompting us to quantify
the intracellular melanin and the melanin released into the
growth medium. Like in B16 cells, the expression of TYR,
TRP1, and DCT was also increased by CYM. The expression
of TYR andDCTwas greater than that of TRP1 in both CYM-
and 𝛼-MSH-treated HEM (Figures 2(c) and 2(d)).
3.4. Transcriptome Changes Induced by CYM. The gene
expression profile of B16 cells treated with CYM relative to
control (untreated cells) was determined using microarrays
that contained 39,000 transcripts targeting mouse genes.
CYMmodulated a total of 11,746 genes. Gene ontology (GO)
and function (biological process) of the modulated genes
were identified usingMouse Genome Informatics (MGI) and
the results showed that CYMdifferentially altered the expres-
sion of genes associated with pigmentation, cytoskeleton
organization, positive JUN kinase activity, and neuron differ-
entiation. Moreover, genes relevant in the metabolic process,
protein transport, negative regulation of cAMP-dependent
protein kinase activity, and cell adhesion were downregu-
lated. A summary of the pigmentation-associated genesmod-
ulated by CYM treatment. (Table 1) showed that CYM upreg-
ulated the expression of the three melanogenic enzymes Tyr,
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Figure 1: Effect of Cymbopogon schoenanthus ethanol extract on melanogenesis in B16 cells. (a) Melanin content (bar graph) and the cell
viability (line graph) of B16 cells treated without (control) or with C. schoenanthus ethanol extract (CYM) at various concentrations (1/10000,
1/1000, or 1/100 v/v). (b) The effect of CYM on the expression of the tyrosinase (TYR), tyrosinase-related protein 1 (TRP1), and dopachrome
tautomerase (DCT). The signals were visualized using LI-COR Odyssey Infrared Imaging System after reaction with goat anti-mouse IRDye
680LT or goat anti-rabbit IRDye 800CW (LI-COR). Results represent the mean ± SD of triplicate samples. ∗Statistically significant (𝑃 ≤ 0.05)
difference between treated cells and control. (c) Protein quantification based on the band intensities from the western blot in (b) determined
using the LI-COR system.
Trp1, and Dct as well as cytoskeleton organization-associated
genes, copper transport and most melanosome transport
genes such as thymosin beta 10 (TMSB 10) and ribosomal pro-
tein S3 (Rps3). The microphthalmia-associated transcription
factor (Mitf)was upregulated 2-fold. As expected, most of the
genes regulated by Mitf were also upregulated (Lamp1, Tyr,
Trp1, Dct, Mlph, Mc1r, Mlana, Slc45a, Rab27a, Tnfrsf14, Irf4,
Lamp3, and Shc4) although some were downregulated (Bcl2,
Ednrb, Tbx2, and Hk2). Mlana, Mlph, Pmel, and Rab38 are
significant formelanosome component or transport and cop-
per ion transport. Genes significant for homeostasis were also
upregulated (Atox1,Atp7b). Upregulation of the transcription
factors Pax3, Sox10, and Lef1 is the most likely cause for
the observed increase in Mitf expression. Elsevier Pathway
Studio analysis further revealed that CYM also affected
the following signal transduction pathways: FOX1, mTOR,
insulin, JNK/MAPK, and Hippo/YAP1 (data not shown).
3.5. Validation of the Microarray Results. Quantifying the
mRNA expression level of the melanogenic enzymes using
real-time PCR validated the microarray results. Results
showed that the mRNA levels of Tyr and Trp1 genes were
significantly increased, 4 h after treatment with CYM or 𝛼-
MSH compared to the control (Figures 3(a) and 3(b)) while
Dct gene expression was only slightly increased (5% increase
compared to the control) (Figure 3(c)). Real-time PCR results
showed that Mitf mRNA expression was increased 4 h after
treatment with CYM and 𝛼-MSH (Figure 4).
4. Discussion
Mammalian skin pigmentation is a result of the biosynthesis
and accumulation of epidermal melanin. Melanin is the most
important photoprotective factor due to its ability to absorb
UV radiation (UVR) and has antioxidant and reactive oxygen
species (ROS) scavenging properties [16]. The production of
melanin, therefore, is critical for inhibiting melanoma, as
exposure to UVR, especially the UVA component, and is
known to initiate oxidative stress in human skin [17, 18]. And
even though there are cosmetics or products, that claim to
BioMed Research International 5
0 1/10000 1/1000 1/100
C. schoenanthus (v/v)
0
20
40
60
80
100
120
C
ell
 p
ro
lif
er
at
io
n 
(%
 o
f c
on
tro
l)
∗
(a)
CON CYM
0
50
100
150
200
250
M
ela
ni
n 
co
nt
en
t (
%
 o
f c
on
tro
l)
-MSH
0
20
40
60
80
100
120
C
ell
 v
ia
bi
lit
y 
(%
 o
f c
on
tro
l) 
∗
∗
(b)
TYR
GAPDH
TRP1
DCT
CON CYM-MSH
(c)
Con CYM
TYR
TRP1
DCT
-MSH
0
20
40
60
80
100
120
140
160
Ba
nd
 in
te
ns
ity
 (%
 o
f c
on
tro
l) 
(d)
Figure 2: Effect of Cymbopogon schoenanthus ethanol extract on melanogenesis in human epidermal melanocytes (HEM). (a) Cell
proliferation evaluated using MTT Assay: HEM (3 × 103 cells/well) were treated with C. schoenanthus ethanol extract (CYM) at various
concentrations (0, 1/10000, 1/1000, or 1/100 v/v) and incubated for 48 h. (b) Melanin content was determined by seeding HEM in 100mm
dish (5 × 105 cells/dish) and treated without (control) or with 1/1000 (v/v) CYM and incubated for 72 h. The bar graph indicates the melanin
content (left-hand 𝑦-axis) while the line graph indicates cell viability (right-hand 𝑦-axis). (c) Expression of the tyrosinase (TYR), tyrosinase-
related protein 1 (TRP1), and dopachrome tautomerase (DCT) was determined using western blotting. Total protein was extracted fromHEM
cultured in 100mmPetri dish (3× 106 cells/dish) and treatedwithout (Con) or with 400 nm alpha-melanocyte-stimulating hormone (𝛼-MSH)
or 1/1000 (v/v) CYM for 48 h. Results represent the mean ± SD of triplicate determinations. ∗Statistically significant (𝑃 ≤ 0.05) difference
between control and treated cells. (d) Protein quantification based on the band intensities from the western blot in (c) determined using the
LI-COR system.
provide sun protection, there is no better protection that that
imparted by melanin itself. Recently, there is an increase in
the number of researches devoted to the evaluation of natural
products or plant extracts to regulate melanogenesis [19, 20].
Here we demonstrated the melanogenesis regulatory
effect ofCymbopogon schoenanthus (CYM) ethanol extract on
B16 cells (Figures 1(a) and 1(b)).The enhancedmelanogenesis
observed in B16 cells was also seen in human epider-
mal melanocytes (HEM) treated with CYM (Figure 2(b)).
Differences between the promoter regions of mouse and
human tyrosinase have been reported [21, 22], but CYM
appears to promote the production of both murine and
human tyrosinase without cytotoxicity (Figures 2(a), 2(b),
and 2(c)). Melanogenesis is the unique process of producing
the melanin within melanosomes and is a major function
of both differentiated normal melanocytes and malignant
melanoma cells [23]. There are two kinds of melanins, the
eumelanin (black-to-brown) and the pheomelanin (yellow-
to-reddish-brown). Melanins are derived from dopaquinone
(DQ). When L-tyrosine is oxidized by TYR, it forms
an intermediate L-3, 4-dihydroxyphenylalanine (DOPA).
Cyclization of DQ’s quinone produce cyclodopa which,
following another redox exchange with another molecule
of DQ, produces DOPAchrome and DOPA, and decompo-
sition of DOPAchrome that produces 5,6-dihydroxyindole
and 5,6-dihydroxyindole-2-carboxylic acid (DHICA). DHI
and DHICA undergo further oxidation and polymerization
to form eumelanins. DCT catalyzes the tautomerization
of DOPAchrome to produce DHICA. TYR mediates the
oxidation of DHICA to the quinone form in humans and by
TRP1 in mice [24]. In this study, 𝛼-melanocyte-stimulating
hormone (𝛼-MSH) was used as a positive control owing to its
ability to induce melanocyte differentiation and melanogen-
esis [25].
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Figure 3: Effect of Cymbopogon schoenanthus ethanol extract on the mRNA expression level of melanogenic enzymes: (a) tyrosinase (Tyr),
(b) tyrosinase-related protein 1 (Trp1), and (c) dopachrome tautomerase (Dct) determined using TaqMan real-time quantitative PCR. B16 cells
were cultured in 100mm dish (3 × 106 cells/dish) and treated without (CON) or with 1/1000 (v/v) C. schoenanthus ethanol extract (CYM),
using 400 nm alpha-melanocyte-stimulating hormone (𝛼-MSH) as a positive control and incubated for 4 h after which RNA was extracted,
and then reverse transcription PCRwas carried out to obtain cDNAs that were used for real-time PCR (ABI 7500 Fast Real-time PCR system).
Results represent themean± SD of three independent experiments. ∗Statistically significant (𝑃 ≤ 0.05) difference between control and treated
cells.
When melanocytes are exposed to oxidative stress, how-
ever, melanogenesis is inhibited because the melanogenic
enzymes or melanocyte differentiation markers TYR, TRP1,
and DCT and the melanogenesis master regulator MITF
[15] are downregulated. CYM is known for its antioxidant
effect owing to its high polyphenol content [26]. Previ-
ously we have reported that CYM can alleviate H
2
O
2
-
induced cytotoxicity in neurotypic cells, and the effect was
attributed to the seven phenolic compounds quercetin-3-
rhamnoside, trans-cinnamic acid, resorcinol, caffeic acid,
and 2.5-dihydroxybenzoic acid, ferulic acid, and gallic acid
present in the extract [13]. Whether the increase in melano-
genesis was a result of the alleviation of oxidative stress in the
cells or not is not discussed here but is a possibility. It is clear,
however, that the stimulation of melanogenesis was the cause
of the synergistic interaction of the bioactive compounds
present in CYM.
The regulatory control ofmelanin biosynthesis is complex
and involves different signaling pathways in response to
hormones, growth factors, cytokines, and neurotransmit-
ters [27]. CYM modulated the expression of pigmentation-
associated genes as well as those that promote cell home-
ostasis (Table 1). The increase in the expression of the
melanogenic enzymes Tyr, Trp1, and Dct expression can
be attributed to the increase in the Mitf expression, which
was increased 2.2-fold. Mitf can be activated by several
transcription factors such as Sox10, Lef1, and Pax3, [23]
which were all upregulated by CYM by 2.5-, 1.5-, and 1.2-
fold, respectively. Another possible reason for the increase
in Mitf expression was the downregulation of Map2k1 that
is the gene that codes for MAPKs ERK1 and ERK2. The
regulation of melanocyte or melanoma or cell differentiation
involves the MAP kinase pathway and the activation of ERKs
is a required event in the initiation of melanogenesis [28].
Phosphorylation of ERK1/2 promotes reducing melanogen-
esis by downregulating Mitf [25]. Another possible reason
for the increased melanogenesis could be the increase in
Atp7b and Atox1 genes expression, with a 2.0-fold and 4.8-
fold increase, respectively (Table 1). Atp7b and Atox1 genes
play an important role in intracellular copper ion transport
and cellular copper ion homeostasis. The key melanogenic
enzyme tyrosinase is a copper-containing enzyme, with two
copper atoms in its active sites, Cu (II) and Cu (I) [29], and
has six copper-binding domains in its N-terminal region and
believed to accept copper from cytoplasmic carriers and/or
assist in delivering copper to the channel [30]. The structure
8 BioMed Research International
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Figure 4: Effect ofCymbopogon schoenanthus ethanol extract on the
mRNA expression level of microphthalmia-associated transcription
factor (Mitf) determined using TaqMan real-time quantitative PCR.
B16 cells were cultured in 100mmdish (3× 106 cells/dish) and treated
without (CON) or with 1/1000 (v/v) C. schoenanthus ethanol extract
(CYM), using 400 nm alpha-melanocyte-stimulating hormone (𝛼-
MSH) as a positive control, and incubated for 4 h after which RNA
was extracted, and then reverse transcription PCR was carried out
to obtain cDNAs that were used for real-time PCR (ABI 7500
Fast Real-time PCR system). Results represent the mean ± SD of
three independent experiments. ∗Statistically significant (𝑃 ≤ 0.05)
difference between control and treated cells.
of the key regulatory enzyme of melanogenesis, tyrosinase,
shows high homology with other tyrosinase-related pro-
teins including TRP1 and DCT, sharing about 40% amino
acid homology with tyrosinase, with which they also have
structural similarity [31]. All three melanogenic enzymes
are transcriptional targets of MITF, the master regulator
of melanocyte development, function, and survival, which
binds to elements shared between their respective promoters
[23]. The fundamental role of MITF in the regulation of
mammalian pigmentation is evidenced by the genetically
determined pigmentary disorders resulting frommutation at
the Mitf (Mi) locus in mice [23, 32]. CYM also differentially
downregulated genes associated with signaling pathways that
activateMitf (e.g., cAMP pathway), as well as those that bind
the ATP and RNA (Table 2).
Components analysis of CYM, using RP-HPLC coupled
with UV-Vis multiwave length detector, identified five phe-
nolic compounds quercetin-3-rhamnoside, trans-cinnamic
acid, resorcinol, caffeic acid, and 2.5-dihydroxybenzoic acid,
ferulic acid, and gallic acid [13]. It is interesting to note that
although the components of CYM, individually, have been
reported to inhibit melanogenesis [33–35], CYM extract has
the opposite effect and suggests that this effect onmelanogen-
esis is due to the synergistic effects between these polyphenols
[35, 36]. The validation of the microarray results was done
using real-time PCR, the results of which showed that CYM
promoted the melanogenic enzymes’ gene expression, 4 h
after treatment. Increasing the treatment time would most
likely cause a significant increase in the expression. CYM has
been reported to mitigate oxidative stress but whether the
observed increase in melanogenesis was a direct effect of this
effect was not determined in this study. A follow-up studywill
be conducted to see if the melanogenesis promotion effect of
CYM was a direct effect of mitigation of oxidative stress.
Plants are valuable source of therapeutic compounds
and their extracts’ complex composition consists of related
compounds with multiple bioactivities, with their synergistic
interaction providing greater total bioactivity [37]. There is a
recognition now of the therapeutic potential of plant extracts
which is essentially a mixture of interacting compounds. In
fact medicinal plants are also subjected to clinical tests to
evaluate for safety and efficacy in the same way conventional
drugs are evaluated, which can be shortened considering
their history of safe human use [38].
5. Conclusion
CYM can promote melanogenesis in B16 cells and HEM
without cytotoxicity. The results of this study suggest that
any CYM-containing cosmetic product or intake of CYM
would have a pigmentation enhancing effect thatmay provide
protection against harmful UV radiation and, thus, may help
prevent melanoma skin cancer. Furthermore, the results in
this study suggest that the combination of compounds at the
concentration which are present in the extract could provide
an insight into the positive interaction between natural
compounds present in CYM. Exploring the possible relation-
ship between its antioxidant effect and the melanogenesis-
promoting effect of CYM, which is not determined here,
would be interesting to explore in future studies. CYM,
with its cell differentiation-induction effect on B16 cells and
melanocytes, has potential application in developing effective
therapeutics against hypopigmentation-related disorders.
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